Dissecting the relationship between heart failure and diabetic retinopathy severity in patients with diabetes and chronic kidney disease: an observational cohort study
- PMID: 40624114
- PMCID: PMC12234909
- DOI: 10.1038/s41598-025-04523-1
Dissecting the relationship between heart failure and diabetic retinopathy severity in patients with diabetes and chronic kidney disease: an observational cohort study
Abstract
Diabetic retinopathy (DR) is associated with increased cardiovascular risk, but evidence of its relationship with heart failure (HF) in people with diabetes and chronic kidney disease (CKD) is limited. Therefore, we examined the association between DR severity and concurrent HF status, as well as the risk of subsequent HF hospitalization in this population. A total of 1,503 patients with both diabetes and CKD underwent fundus photography. DR severity was classified into three groups: Group 1 (no apparent DR, mild non-proliferative DR [NPDR], moderate NPDR), group 2 (severe NPDR, very severe NPDR), and group 3 (proliferative DR [PDR], and high-risk PDR). Associations between HF status and DR severity were analyzed using ordinal regression. Cox proportional hazard models examined the association between DR severity and subsequent HF hospitalization. HF was positively associated with worse DR grade (adjusted odds ratio 2.09, 95% confidence interval [CI] 1.37-3.18). In patients without HF at baseline, a higher incidence of acute HF hospitalization over 5 years was identified in group 2 (hazard ratio 1.37, 95% CI 0.83-2.26) and group 3 (hazard ratio 1.86, 95% CI 1.22-2.83) compared to patients with less severe DR. In summary, DR severity is independently associated with both concurrent HF and risks for HF hospitalization over 5 years among those with diabetes and CKD and could aid cardiovascular risk stratification.
Keywords: Chronic kidney disease; Diabetes mellitus; Diabetic retinopathy; Heart failure.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
Figures




Similar articles
-
Fenofibrate for diabetic retinopathy.Cochrane Database Syst Rev. 2023 Jun 13;6(6):CD013318. doi: 10.1002/14651858.CD013318.pub2. Cochrane Database Syst Rev. 2023. PMID: 37310870 Free PMC article.
-
Different lasers and techniques for proliferative diabetic retinopathy.Cochrane Database Syst Rev. 2018 Mar 15;3(3):CD012314. doi: 10.1002/14651858.CD012314.pub2. Cochrane Database Syst Rev. 2018. PMID: 29543992 Free PMC article.
-
Diabetic retinopathy and chronic kidney disease synergistically increase the risk of incident cardiovascular disease in type 2 diabetes: Insights from two cohort studies.Diabetes Res Clin Pract. 2025 Aug;226:112373. doi: 10.1016/j.diabres.2025.112373. Epub 2025 Jul 10. Diabetes Res Clin Pract. 2025. PMID: 40651533
-
Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation.Health Technol Assess. 2015 Jul;19(51):v-xxviii, 1-247. doi: 10.3310/hta19510. Health Technol Assess. 2015. PMID: 26173799 Free PMC article.
-
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.Cochrane Database Syst Rev. 2023 Jul 19;7(7):CD007751. doi: 10.1002/14651858.CD007751.pub3. Cochrane Database Syst Rev. 2023. PMID: 37466151 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
- NSTC 113-2314-B-037 -097 -MY3/Ministry of Science and Technology, Taiwan
- KMUH111-1M09, KMUH112-2M08, KMUH113-3R19, KMUH111-1M09, KMUH-DK(B)110003-1/Kaohsiung Medical University Chung-Ho Memorial Hospital
- NPUST-KMU-111-P001, NPUST-KMU-114-P001, KT112P012, KT113P006, KMUH-DK(C)112001, NHRIKMU-111-I001-3/Kaohsiung Medical University
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous